MineralsMagnesium

Combined apigenin and magnesium synergistically enhance sleep duration in normal and insomnia mouse models

The combination of apigenin and magnesium (A+M) significantly increased sleep duration by 44% in normal mice, 32% in caffeine-induced sleep-disturbed mice, and 37% in PCPA-induced insomnia mice, outperforming individual treatments. Mechanistically, A+M suppressed systemic and hypothalamic TNFα levels and inhibited microglial activation via NFκB signaling.

Last updated: Jul 8, 20260 RCTs📖 Read as article →

Evidence Score

Evidence Score26/100
Human RCT☆☆☆☆☆
Meta-analysis☆☆☆☆☆
Mechanism★★★★★
Safety★★★★
Confidencelow

Study Evidence

Study 1. Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models.

observational

Wong WY, Chan BD, Zhou H, Leung TC, Tai WC · Food & function (2026)

Participants: N/A
Duration: N/A (not specified in abstract)
Intervention: Combined oral administration of apigenin and magnesium (A+M)
Outcome: Sleep duration, TNFα levels, microglial activation
Effect Size: 44% increase (normal mice, p<0.005), 32% increase (caffeine model, p<0.001), 37% increase (PCPA model, p<0.05)
Population: Normal mice, caffeine-induced sleep-disturbed mice, and PCPA-induced insomnia mice

Result:

Mechanism Graph

A+M treatment suppresses systemic and hypothalamic TNFα levels
A+M inhibits microglial activation
Inhibition of microglial activation occurs via suppression of NFκB signaling
Result: Enhanced sleep duration and restored sleep architecture

Limitations

  • Animal model study, not directly translatable to humans
  • Dosage and formulation details not provided in abstract
  • Potential confounding effects from individual variability in mouse strains

Frequently Asked Questions

What is the synergistic effect of apigenin and magnesium on sleep?

The combination increased sleep duration by 44% in normal mice and significantly improved sleep in insomnia models, outperforming either compound alone.

How does apigenin and magnesium improve sleep mechanistically?

The combination suppresses TNFα levels and inhibits microglial activation through NFκB signaling, reducing neuroinflammation.

Is this study applicable to humans?

No, this is an animal model study; human trials are needed to confirm efficacy and safety.

What are the limitations of this study?

Limitations include animal model use, unspecified dosage, and lack of human data, making direct clinical application uncertain.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Wong WY, Chan BD, Zhou H, Leung TC, Tai WC. "Synergistic sleep-promoting effects of magnesium and apigenin in normal and insomnia mouse models.." Food &amp; function, 2026. PMID: 41701207 DOI: 10.1039/d5fo04538j
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.